Pre-market hot trades in US stocks: Zeta Network up 70.55% in pre-market; Greenland Energy up 50.91% in pre-market

Pre-market Hot Trades in US Stocks Zeta Network, up 70.55% in pre-market trading, has no significant news recently. The trading is active, with clear capital flows. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. Greenland Energy is up 50.91% in pre-market trading. Based on recent key news: On March 30, Greenland Energy signed a five-year drilling agreement with Stampede Drilling to secure rig capacity for the Arctic drilling project in 2026. This agreement ensures the availability of Stampede's Rig No. 12, which is suitable for Arctic conditions and can mobilize teams to execute drilling tasks. This news drove the company's stock price up in after-hours trading. Source: Dolphin Research. The energy sector has recently experienced significant fluctuations due to policy impacts. Top Gainers in Pre-market US Stocks PMGC is up 77.84% in pre-market trading. Based on recent key news: On March 27, PMGC Holdings, through its subsidiary NorthStrive Biosciences, signed a third amended licensing agreement with the South Korean biotechnology company MOA Life Plus. This amendment adjusts the timelines and key development milestones for the EL-32 and EL-22 human clinical projects to better align with both parties' research, development, and regulatory expectations. This news significantly boosted PMGC's stock price. On March 27, PMGC Holdings announced it would pay MOA Life Plus the consideration within 30 days of the agreement's execution and effective date. This financial commitment demonstrates the company's emphasis on project development, further enhancing market confidence. On March 27, NorthStrive Biosciences' EL-22 was described as its main asset, utilizing an engineered probiotic approach aimed at preserving muscle during weight loss treatment. The potential of this innovative technology sparked positive reactions from investors, driving the stock price up. The biotechnology industry is innovation-driven, with high market attention. Iterum Therapeutics is up 36.24% in pre-market trading. Based on recent key news: On March 27, Iterum Therapeutics announced it had submitted a liquidation application to the High Court of Ireland, appointing Damien Murran and Jennifer McMahon from Teneo Restructuring as interim liquidators to oversee the liquidation process. This move led to fluctuations in the company's stock price. On March 27, the company disclosed that its drug would generate $400,000 in revenue after its launch in the third quarter of 2025, but if the court approves the liquidation order, the company will undergo orderly liquidation and ultimately dissolve On March 28, Iterum Therapeutics initiated liquidation proceedings and announced leadership exits, further exacerbating market uncertainty about the company's future. The pharmaceutical industry is facing policy and market challenges. Astrotech, up 32.49% in pre-market trading, has had no significant news recently. Trading is active, with clear capital flows. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation